de Dios, A, Pages-Puigdemont, N, Ojeda, S, Riera, P, Pelegrín, R, Morollon, N, Belvís, R, Real, J, Masip, M. Persistence, effectiveness, and tolerability of anti-calcitonin gene-related peptide monoclonal antibodies in patients with chronic migraine. HEADACHE. 2025; 65(1)DOI:10.1111/head.14827. PMID:39268992. IF:4.000(Q1/2D).

Ruiz-Ramos, J, Alquézar-Arbé, A, Juanes-Borrego, A, González-del-Castillo, J, Jacob, J, Burillo, G, Aguiló, S, Fernandez, C, Plaza-Díaz, A, Millán-Soria, J, Jara-Torres, G, López-Delmas, N, Muñoz-Triano, E, Martín-Durán, C, Delgado-Sardina, V, Gallardo-Sánchez, BA, Osorio-Quispe, IG, Real-López, A, Gordo-Remartinez, S, González-Ferreira, L, alvarez-Madrigal, A, Martínez-Ibarreta-Zorita, J, Sanchez-Moreno, M, Sanchez-Moreno, M, Sánchez-Serrano, JA, Hernando-Fernández, R, Turcios-Torres, J, Ponte-Márquez, P, Miró, O. Association of Benzodiazepine Prescription With Short-Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024; 33(11)DOI:10.1002/pds.70044. PMID:39477694. IF:2.400(Q2/4D).

Martinez-Molina, C, Tey, JMG, Ruiz-Ramos, J, Feliu, A, Puig-Campmany, M, Vidal, S, Corominas, H. Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis. MEDICINA CLINICA. 2024; 163(8)DOI:10.1016/j.medcli.2024.05.007. PMID:39003114. IF:2.100(Q2/3D).

Zarate-Tamames, B, Garin, N, Calvin-Lamas, M, Jornet, S, Martinez-Simon, JJ, Garcia-Gil, S, Garcia-Rebolledo, EM, Morillo-Verdugo, R. Transforming respiratory diseases management: a CMO-based hospital pharmaceutical care model. Frontiers in Pharmacology. 2024; 15DOI:10.3389/fphar.2024.1461473. PMID:39512818. IF:4.800(Q1/2D).

Redondo, S, Costa, M, Moreno-Martinez, ME, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. DEVELOPMENT AND CLINICAL VALIDATION OF LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY FOR INDIVIDUALIZED RUXOLITINIB ADJUSTMENT IN FUTURE CASES OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Redondo, S, Arrufat, A, Esquirol, A, Saavedra, S, Arguello-Tomas, M, Caballero, AC, O ate, G, Garrido, A, Lopez, J, Miqueleiz, S, Portos, JM, Iranzo, E, Moreno-Martinez, ME, Riba, M, Sierra, J, Briones, J, Garc a-Cadenas, I, Martino, R. EFFICACY AND SAFETY OF REDUCED-DOSES OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PERIPHERAL BLOOD STEM CELL TRANSPLANTATION OUTSIDE THE HAPLOIDENTICAL SETTING. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Tobajas, E, Carretero, G, De Dios, A, Redondo, S, Vallv , M, Esquirol, A, Aso, O, Triquell, M, Moreno-Martinez, ME, Riba, M, Blasco, A, Martino, R, Gomis-Pastor, M, Garc a-Cadenas, I. EVALUATION OF MENTAL HEALTH THROUGH AN EHEALTH PLATFORM IN THE MANAGEMENT OF ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS (MYMEDULA STUDY): DESCRIPTIVE ANALYSIS. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Redondo, S, De Dios, A, Vallve, M, Real, J, Triquell, M, Aso, O, Esquirol, A, Moreno-Martinez, M, Riba, M, Ruiz, J, Tobajas, E, Sierra, J, Briones, J, Martino, R, Gomis-Pastor, M, Garcia-Cadenas, I. MOBILE HEALTH IN THE MANAGEMENT OF ALLOGENIC STEM CELL TRANSPLANT RECIPIENTS (MY-MEDULA STUDY): PRELIMINARY RESULTS OF THE CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Triquell, M, Redondo, S, De Dios, A, Vallv , M, Real, J, Esquirol, A, Martinez, EM, Riba, M, Tobajas, E, Sierra, J, Briones, J, Martino, R, Ruiz, J, Pastor, MG, Cadenas, IG, Aso, O. NURSING ROLE IN IMPLEMENTING EHEALTH FOR ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS: INITIAL FINDINGS FROM THE MY-MEDULA STUDY'S RANDOMIZED CLINICAL TRIAL. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

Domingos, V, Nezvalova-Henriksen, K, Dadkhah, A, Moreno-Martinez, ME, Ben Hassine, K, Pires, V, Kroeger, N, Bauters, T, Hassan, M, Duncan, N, Kalwak, K, Ansari, M, Langebrake, C, Admiraal, R. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). BONE MARROW TRANSPLANTATION. 2024; 59(12)DOI:10.1038/s41409-024-02413-0. PMID:39271948. IF:5.200(Q1/1D).

Gras-Martín, L, Plaza-Diaz, A, Zarate-Tamames, B, Vera-Artazcoz, P, Torres, OH, Bastida, C, Soy, D, Ruiz-Ramos, J. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090801. PMID:39334976. IF:4.600(Q1/2D).

Collado-Borell, R, Gomis-Pastor, M, Rodríguez-Cabezas, M, Parro-Martín, A, Linares-Alarcón, A, Gutiérrez, E, González-Corominas, E, Fernández-Polo, A, Domínguez-Cantero, M, Arrondo-Velasco, A, Morillo-Verdugo, R. Guide for the efficient and safe delivery of Telepharmacy. Health Policy and Technology. 2024; 13(4)DOI:10.1016/j.hlpt.2024.100899. PMID:. IF:3.700(Q1/1D).

de Gamarra-Martínez, EF, Tortajada-Goitia, B, Corte-García, JJ, Martín-Herranz, I, García-Gil, M, de la Fuente, JS, Nicolás-Picó, J. Hospital pharmacy towards 2030. Farmacia Hospitalaria. 2024; 48DOI:10.1016/j.farma.2024.05.004. PMID:39097369. IF:(Q/D).

De Pourcq, JT, Riera, A, Gras, L, Garin, N, Busquets, MA, Cardenete, J, Cardona, D, Riera, P. Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition. Pharmaceuticals. 2024; 17(7)DOI:10.3390/ph17070896. PMID:39065746. IF:4.800(Q1/2D).

Abraldes, MJ, Calvo, P, Lechuga, MG, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Ruiz-Moreno, JM. Burden of Disease Study of Patients with Neovascular Age-Related Macular Degeneration in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00960-9. PMID:38771461. IF:3.200(Q1/2D).

Ruiz-Moreno, JM, Lechuga, MG, Calvo, P, Merino, M, Lorenzo, TM, Maravilla-Herrera, P, Jiménez, BG, Abraldes, MJ. Burden of Disease Study of Patients with Diabetic Macular Oedema in Spain. Ophthalmology and Therapy. 2024; 13(7)DOI:10.1007/s40123-024-00959-2. PMID:38771462. IF:3.200(Q1/2D).

Garin, N, Zarate-Tamames, B, Jornet, S, García, EM, López-Gil, MD, Romero, G, Del Estal, J. Pharmaceutical care in respiratory diseases: Current situation and opportunities for Hospital Pharmacy in Spain. Farmacia Hospitalaria. 2024; 48(4)DOI:10.1016/j.farma.2024.02.006. PMID:38580504. IF:(Q/D).

Moreno-Martinez, ME, Riba, M, García-Cadenas, I, Esquirol, A, Yusta, M, Redondo, S, De Dios, A, Portos, JM, Aso, O, Marcos-Fendian, A, Font, N, Briones, J, Martino, R, Feliu, A. Optimization of a home hospitalization program for hematopoietic stem cell transplantation with ehealth integration and clinical pharmacist involvement. Frontiers in Immunology. 2024; 15DOI:10.3389/fimmu.2024.1397115. PMID:38919607. IF:5.900(Q1/2D).

Gomis-Pastor, M, Berdún, J, Borrás-Santos, A, López, AD, Rama, BFM, García-Esquirol, O, Gratacòs, M, Rodríguez, GDO, Cruz, RP, Real, J, Ferrer, JBI, Comella, A. Clinical Validation of Digital Healthcare Solutions: State of the Art, Challenges and Opportunities. Healthcare. 2024; 12(11)DOI:10.3390/healthcare12111057. PMID:38891132. IF:2.700(Q2/4D).

Burgos, A, Calleja, T, Ibáñez, C, Valencia, CM, Orallo, C, Titos, JC, Conde, D, Diaz, S, Matilla, B, Lizeaga, G, Sánchez, C, Pozo, JFM, Jimenez, S, Jiménez, I, Díez, R, Garrido, M, Larrosa, M, Martinez, MJ, Moreno, E, Campelo, RG. First-line pembrolizumab for lung cancer in a Spanish real-world study.. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).